Mirae Asset Global Investments’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6K | Buy |
3,374
+532
| +19% | +$1.99K | ﹤0.01% | 1458 |
|
|
2025
Q1 | $8.3K | Buy |
2,842
+12
| +0.4% | +$35 | ﹤0.01% | 1486 |
|
|
2024
Q4 | $16.3K | Buy |
2,830
+285
| +11% | +$1.64K | ﹤0.01% | 1450 |
|
|
2024
Q3 | $21.8K | Buy |
2,545
+614
| +32% | +$5.25K | ﹤0.01% | 1421 |
|
|
2024
Q2 | $13.7K | Buy |
+1,931
| New | +$13.7K | ﹤0.01% | 1432 |
|
|
2024
Q1 | – | Sell |
-40,679
| Closed | -$264K | – | 2644 |
|
|
2023
Q4 | $264K | Buy |
40,679
+108
| +0.3% | +$701 | ﹤0.01% | 2247 |
|
|
2023
Q3 | $204K | Buy |
40,571
+154
| +0.4% | +$775 | ﹤0.01% | 2288 |
|
|
2023
Q2 | $354K | Buy |
+40,417
| New | +$354K | ﹤0.01% | 2108 |
|